Page last updated: 2024-11-05

2,4-thiazolidinedione and Cancer of Head

2,4-thiazolidinedione has been researched along with Cancer of Head in 1 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Research Excerpts

ExcerptRelevanceReference
"Human oral cancer CA-9-22 and NA cell lines were treated with the PPAR activators eicosatetraynoic acid (ETYA), 15-deoxy-δ- 12,14-prostaglandin J2 (PG-J2), and the thiazolidinedione, ciglitazone, and evaluated for their ability to functionally activate PPARγ luciferase reporter gene constructs."1.46Functional activation of PPARγ in human upper aerodigestive cancer cell lines. ( Abu Ghazallah, R; Gaffney, PM; Harris, G; Miller, WA; Ondrey, FG; Wright, SK; Wuertz, BR, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wright, SK1
Wuertz, BR1
Harris, G1
Abu Ghazallah, R1
Miller, WA1
Gaffney, PM1
Ondrey, FG1

Other Studies

1 other study available for 2,4-thiazolidinedione and Cancer of Head

ArticleYear
Functional activation of PPARγ in human upper aerodigestive cancer cell lines.
    Molecular carcinogenesis, 2017, Volume: 56, Issue:1

    Topics: Antineoplastic Agents; Arachidonic Acids; Cell Line; Cell Line, Tumor; Cell Proliferation; Gene Expr

2017